Status:

RECRUITING

Living With Marfans and Your Aorta: Surgical Outcomes Study

Lead Sponsor:

Barts & The London NHS Trust

Collaborating Sponsors:

Liverpool Heart and Chest Hospital NHS Foundation Trust

Aortic Dissection Awareness UK & Ireland.

Conditions:

Marfan Syndrome

Marfan Syndrome Cardiovascular Manifestations

Eligibility:

All Genders

18-120 years

Brief Summary

Marfan Syndrome (MFS) is a genetic disease affecting the eyes, skeleton, heart and arteries. Despite MFS affecting multiple organ systems, cardiovascular manifestations are the most serious and life t...

Detailed Description

Marfan Syndrome (MFS) is a rare autosomal-dominant connective tissue disorder with pleiotropic manifestations primarily affecting the skeletal, ocular, and cardiovascular systems. Despite MFS affectin...

Eligibility Criteria

Inclusion

  • \>/= 18 years old at the time of surgery;
  • have validated diagnosis of MFS (using revised Ghent criteria);
  • having aorto-vascular surgery

Exclusion

  • \<18years old at the time of surgery
  • Unable or unwilling to give written informed consent.
  • Inability to understand written and/or verbal English

Key Trial Info

Start Date :

July 26 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

28 Patients enrolled

Trial Details

Trial ID

NCT04776681

Start Date

July 26 2021

End Date

December 31 2025

Last Update

January 7 2026

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

St Bartholomews Hospital

London, United Kingdom, EC1A 7BE